Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Behringwerke Rabipur rabies vaccine is comparable to current vaccines; company says it could cost less.

Executive Summary

BEHRINGWERKE RABIPUR WILL COST LESS THAN OTHER RABIES VACCINES currently on the market, the company told FDA's Vaccines & Related Biological Products Advisory Committee Jan. 29. Pasteur Merieux' Imovax rabies vaccine costs $90 to $135 per 1 mL dose, according to Behringwerke, while the Michigan Department of Public Health's vaccine costs over $150 per 1 mL dose. The company would not disclose a proposed price but told the committee it would be lower than the other two.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS027573

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel